Increased phosphorylation of the MAPK extracellular signal-regulated kinase 1/2 (ERK1/2, a pro-survival molecule) was observed in DM and AMPK-DN mice subjected to MI/R (41.1% and 68.8% respectively) treated by SF-PreCon. The gene discussed is MAPK3; the disease is diabetes mellitus.